SAN DIEGO, Aug. 29, 2012 /PRNewswire/ --Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company’s President and CEO Ted Schroeder will present the company’s corporate overview on Wednesday, September 5, 2012 at 2:40pm Eastern Time (11:40am Pacific Time) during the Stifel Nicolaus Healthcare Conference at the Four Seasons Hotel in Boston.
The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals’ website at www.cadencepharm.com in the Investors section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals’ corporate overview may be viewed on the “Investors” page of www.cadencepharm.com under “Events and Presentations.”
Contacts: | William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400 |
SOURCE Cadence Pharmaceuticals, Inc.
